Global Eubiotics Market Overview

Global Eubiotics Market was valued at USD 5.57 Billion in 2021 and is expected to reach USD 9.25 Billion by the year 2028, at a CAGR of 7.52%.

Eubiotics refer to the products that are utilized for sustaining an effective balance of microflora in the gastrointestinal tract. Eubiotics are required for making well-nourished animals. Eubiotics secure that a healthy balance of micro-flora is maintained in the gastrointestinal tract of an animal. The development in the market can be attributed to scaling global meat and meat products consumption, primarily chicken meat and eggs owing to shifts in diet and food consumption motif toward livestock imitative and the rising global population. Furthermore, biotics is expected to be the required feed additive, which fills the vacuum created by the antibiotics ban. The capitalization of this vacuum is tough in the success of eubiotics, as antibiotics, irrespective of their health or environmental hazards, supplied important capability to the meat manufacturing processes. This impact is further built up by the comprehensive mode of action of eubiotics instead of a compressed local impact. Additionally, the rising production capabilities and materialism of farming in various developing nations are pushing the growth of the eubiotics market. Eubiotics support adequate nutrient absorption required for normal working of the body. Growing demand for protein-based animal products as well as prohibited usage of antibiotics and rising living standards are the key driving forces for the growth of the eubiotics market.

COVID-19 Impact on Eubiotics Market

As long as the COVID-19 virus outbreak in December 2019, the disease has spread to almost every nation over the globe with the World Health Organization announcing it as a public health emergency. The global influence of the coronavirus disease 2019 (COVID-19) is already initiating to be felt, and will remarkedly affect the eubiotics market in 2020. The outbreak of COVID-19 has brought effects on various aspects, such as flight cancellations, travel restrictions and quarantines, restaurants and hotels closed, all indoor/outdoor events restricted, over forty economies state of emergency announced, huge slowing of the supply chain, stock market instability, falling business confidence, increasing panic among the population.

Market Dynamics And Factors

Drivers:

The Growing prevalence of livestock diseases over the world represents one of the key factors creating a positive outlook for the market. Consumption of eubiotics-based feed provides required nutrients and health and medicinal benefits to livestock, such as prevention and timely treatment of chronic diseases. Additionally, rising consciousness among consumers about feed quality and safety also driving market growth.

Eubiotics are extensively used as a substitute for antimicrobial growth promoters (AGPs) in animals and livestock. According to this, the rising demand for animal meat and protein is also contributing to the increasing demand for Eubiotics. In addition, various technological innovations, such as the use of innovative microbiological solutions to create novel product variants with targeted results and easy digestibility, are contributing to market growth. Other factors, such as the rapid modernization of the livestock industry, along with the growing domestication of animals as pets, primarily in the developed economies, are anticipated to drive the market further.

Moreover, growing meat consumption owing to large scale meat production along with easy accessibility of meat products such as to accelerate product demand. According to the research study, the global meat market was around USD 40 billion in 2018 due to growing disposable income and switching dietary patterns. Global meat production was about 323 million tons in 2017. Boost in disposable incomes along with high growth in the processed food & beverage industry will lead the eubiotics market demand over the forecast period.

Restraints:

Stringent government regulations and high manufacturing costs are some of the prime restraining the growth of the global eubiotics market. In addition, inadequate essential oils availability in animal feed applications due to factors like high demand from other applications, such as medical and food and beverages, is hampering the market growth.

Opportunities:

An increasing demographics and economies in emerging countries such as India and China are anticipated to create good opportunities in the eubiotics market in Asia. Additionally, growth in demand for feed additives owing to the rising cost of natural feed products, prohibition on the usages of antibiotics for growth enhancers, rising demand for meat consumption, product innovations, and growth in consciousness associated with the benefits of eubiotics products in animal health are anticipated to create lucrative opportunities for global eubiotics market. Growing investments and opportunities in the animal nutrition and pet animal industry, also rising consumer consciousness towards animal health will create profitable opportunities in the upcoming years.

Market Segmentation

Segmentation Insights

Based on the Product Type, the prebiotics segment is projected to account for the largest demand during the forecast period. Inulin and mannan-oligosaccharides (MOS) are the highly utilized prebiotics for the animal feed industry. Prebiotics dietary fibers are specially fed to animals to boost secretion of digestive enzymes to improve digestive metabolism helped by rising immune to defense to them from environmental conditions. Prebiotics decreases the prevalence of pathogens in the food chain by controlling digestive health. Livestock producers' adoption of natural growth promoters and nutrients to rise performance, feed efficiency, and weight gain should accelerate the eubiotics market growth.

Based on Function, nutrition and gut health segment dominates the market growth over the forecast period. Gut infections may lead to less efficiency, low yield along with additional cost in treatments and trade losses which has resulted in the requirement of eubiotics products to control gut integrity and functionality. growing influence towards animal health and nutrition to defense against further losses should contribute towards the eubiotics market.

Based on Form, dry for projected to dominates the market over the forecast period. Dry form eubiotics required less storage requirement, ease in transportation, and low transportation cost. The dry form provides enhanced stability and longer shelf life for the product. Rising consciousness regarding animal health and nutrition along with growing demand for cost-effective feeds should favor the eubiotics market growth. Key Players are investing in biotechnological solutions in an attempt to enhance nutritional content in powder preparations by producing hybrid strains and enzymes which is probable to hasten market growth in the projected period.

Based on Livestock, poultry dominates the largest market share in the projected period. Poultry is widely consumed over the globe and is a highly farmed livestock. Prebiotics and probiotics are prominently utilized for poultry nutrition to boost digestion, animal growth, and improve the immune system. Eggs and chicks are permitting to high environmental stress and infections from harmful bacteria such as Salmonella and E. coli. Probiotics support overcoming the gut pH thereby helping in competing with bad bacteria and accelerating the immune system.

Regional Insights

The European region accounted for the largest share in the eubiotics market during the forecast period. Efforts taken by livestock manufacturers to comply with the prevalent regulations and prohibitions on applications of antibiotics are resulting in high product demand. Strong awareness associated with the application of eubiotics and their benefits, the presence of market players, and strong demand from economies such as Germany, the U.K., France, and Spain are factors driving the overall regional demand. Moreover, Germany is the top producer of poultry in the region. In addition, Germany has a remarkable presence of industry participants of other livestock such as swine and cattle. Furthermore, the presence of regional as well as international market players in the U.K. is also supporting market growth.

The Asia Pacific held a considerable share in the market during the forecast period. Countries such as India, Japan, South Korea, and China together recorded for the majority of the product sales. A positive outlook towards livestock businesses due to high government and private sector investments in this sector should have a positive impact on regional eubiotics market sales. Growing awareness among farmers and livestock businesses about animal health & nutrition owing to disease outbreaks and the need to help healthy animal food products should accelerate product demand.

North America region expected to growth of the market in the projected period, owing to increasing animal health concern about eubiotics in the animal feed, also growing demand for meat and poultry product are significant factors responsible for growth for eubiotics market in the region.

Key Industry Developments

  • In March 2017, Novozymes and Boehringer Ingelheim are both declared a strategic partnership in probiotics for poultry hatcheries. Additionally, in August 2017, Cargill designed a fermented vegetable feed, high in organic acid for shrimp that can overcome the spread of Early Mortality Syndrome (EMS).
  • In September 2016, Cargill funded USD 146 million to the feed plant at Bathinda, Punjab, India. The unit supply nutritious and safe quality feed to dairy farmers in the states of Punjab, Haryana, Uttar Pradesh, and Rajasthan. It takes around 120,000 metric tons of feed per month and feeds 75,000 cows each day.

Players Covered in Eubiotics market are :

Global Eubiotics Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 5.57 Bn.

Forecast Period 2022-28 CAGR:

7.52%

Market Size in 2028:

USD 9.25 Bn.

Segments Covered:

By Product Type

  • Probiotics
  • Prebiotics
  • Exogenous Enzymes
  • Organic Acids
  • Others

By Form

  • Dry
  • Liquid

By Function

  • Nutrition & Gut Health
  • Production
  • Yield
  • Immunity

By Livestock

  • Ruminant
  • Swine
  • Poultry
  • Aquaculture

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Prevalence of Livestock Diseases in the World

Key Market Restraints:

  • High Cost of Eubiotics

Key Opportunities:

  • High Demand for Feed Additives Owing to the Rising Cost Of Natural Feed Products

Companies Covered in the report:

  • BASF SE, Lallemand Inc., Cargill Incorporated, Calpis Co. Ltd, Chr. Hansen A/S., Kemin Industries Inc., and Other Major Players

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Form
 3.3 By Function
 3.4 By Livestock

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Eubiotics Market by Product Type
 5.1 Eubiotics Market Overview Snapshot and Growth Engine
 5.2 Eubiotics Market Overview
 5.3 Probiotics
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Probiotics: Grographic Segmentation
 5.4 Prebiotics
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Prebiotics: Grographic Segmentation
 5.5 Exogenous Enzymes
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Exogenous Enzymes: Grographic Segmentation
 5.6 Organic Acids
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Organic Acids: Grographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Grographic Segmentation

Chapter 6: Eubiotics Market by Form
 6.1 Eubiotics Market Overview Snapshot and Growth Engine
 6.2 Eubiotics Market Overview
 6.3 Dry
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Dry: Grographic Segmentation
 6.4 Liquid
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Liquid: Grographic Segmentation

Chapter 7: Eubiotics Market by Function
 7.1 Eubiotics Market Overview Snapshot and Growth Engine
 7.2 Eubiotics Market Overview
 7.3 Nutrition & Gut Health
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Nutrition & Gut Health: Grographic Segmentation
 7.4 Production
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Production: Grographic Segmentation
 7.5 Yield
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Yield: Grographic Segmentation
 7.6 Immunity
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Immunity: Grographic Segmentation

Chapter 8: Eubiotics Market by Livestock
 8.1 Eubiotics Market Overview Snapshot and Growth Engine
 8.2 Eubiotics Market Overview
 8.3 Ruminant
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Ruminant: Grographic Segmentation
 8.4 Swine
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Swine: Grographic Segmentation
 8.5 Poultry
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Poultry: Grographic Segmentation
 8.6 Aquaculture
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Aquaculture: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Eubiotics Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Eubiotics Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Eubiotics Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 BASF SE
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 LALLEMAND INC.
 9.4 CARGILL INCORPORATED
 9.5 CALPIS CO. LTD
 9.6 CHR. HANSEN A/S.
 9.7 KEMIN INDUSTRIES INC.
 9.8 LESAFFRE GROUP
 9.9 ADVANCED BIONUTRITION CORPORATION
 9.10 BEHN MEYER
 9.11 KONINKLIJKE DSM N.V.
 9.12 NOVOZYMES.
 9.13 FRIESLAND CAMPINA
 9.14 ALLTECH
 9.15 NOVUS INTERNATIONAL
 9.16 E.I.DU PONT DE NEMOURS AND COMPANY
 9.17 OTHER MAJOR PLAYERS

Chapter 10: Global Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Product Type
  10.2.1 Probiotics
  10.2.2 Prebiotics
  10.2.3 Exogenous Enzymes
  10.2.4 Organic Acids
  10.2.5 Others
 10.3 Historic and Forecasted Market Size By Form
  10.3.1 Dry
  10.3.2 Liquid
 10.4 Historic and Forecasted Market Size By Function
  10.4.1 Nutrition & Gut Health
  10.4.2 Production
  10.4.3 Yield
  10.4.4 Immunity
 10.5 Historic and Forecasted Market Size By Livestock
  10.5.1 Ruminant
  10.5.2 Swine
  10.5.3 Poultry
  10.5.4 Aquaculture

Chapter 11: North America Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Probiotics
  11.4.2 Prebiotics
  11.4.3 Exogenous Enzymes
  11.4.4 Organic Acids
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Form
  11.5.1 Dry
  11.5.2 Liquid
 11.6 Historic and Forecasted Market Size By Function
  11.6.1 Nutrition & Gut Health
  11.6.2 Production
  11.6.3 Yield
  11.6.4 Immunity
 11.7 Historic and Forecasted Market Size By Livestock
  11.7.1 Ruminant
  11.7.2 Swine
  11.7.3 Poultry
  11.7.4 Aquaculture
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Probiotics
  12.4.2 Prebiotics
  12.4.3 Exogenous Enzymes
  12.4.4 Organic Acids
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Form
  12.5.1 Dry
  12.5.2 Liquid
 12.6 Historic and Forecasted Market Size By Function
  12.6.1 Nutrition & Gut Health
  12.6.2 Production
  12.6.3 Yield
  12.6.4 Immunity
 12.7 Historic and Forecasted Market Size By Livestock
  12.7.1 Ruminant
  12.7.2 Swine
  12.7.3 Poultry
  12.7.4 Aquaculture
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Probiotics
  13.4.2 Prebiotics
  13.4.3 Exogenous Enzymes
  13.4.4 Organic Acids
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Form
  13.5.1 Dry
  13.5.2 Liquid
 13.6 Historic and Forecasted Market Size By Function
  13.6.1 Nutrition & Gut Health
  13.6.2 Production
  13.6.3 Yield
  13.6.4 Immunity
 13.7 Historic and Forecasted Market Size By Livestock
  13.7.1 Ruminant
  13.7.2 Swine
  13.7.3 Poultry
  13.7.4 Aquaculture
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product Type
  14.4.1 Probiotics
  14.4.2 Prebiotics
  14.4.3 Exogenous Enzymes
  14.4.4 Organic Acids
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Form
  14.5.1 Dry
  14.5.2 Liquid
 14.6 Historic and Forecasted Market Size By Function
  14.6.1 Nutrition & Gut Health
  14.6.2 Production
  14.6.3 Yield
  14.6.4 Immunity
 14.7 Historic and Forecasted Market Size By Livestock
  14.7.1 Ruminant
  14.7.2 Swine
  14.7.3 Poultry
  14.7.4 Aquaculture
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Eubiotics Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Product Type
  15.4.1 Probiotics
  15.4.2 Prebiotics
  15.4.3 Exogenous Enzymes
  15.4.4 Organic Acids
  15.4.5 Others
 15.5 Historic and Forecasted Market Size By Form
  15.5.1 Dry
  15.5.2 Liquid
 15.6 Historic and Forecasted Market Size By Function
  15.6.1 Nutrition & Gut Health
  15.6.2 Production
  15.6.3 Yield
  15.6.4 Immunity
 15.7 Historic and Forecasted Market Size By Livestock
  15.7.1 Ruminant
  15.7.2 Swine
  15.7.3 Poultry
  15.7.4 Aquaculture
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

Global Eubiotics Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 5.57 Bn.

Forecast Period 2022-28 CAGR:

7.52%

Market Size in 2028:

USD 9.25 Bn.

Segments Covered:

By Product Type

  • Probiotics
  • Prebiotics
  • Exogenous Enzymes
  • Organic Acids
  • Others

By Form

  • Dry
  • Liquid

By Function

  • Nutrition & Gut Health
  • Production
  • Yield
  • Immunity

By Livestock

  • Ruminant
  • Swine
  • Poultry
  • Aquaculture

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Prevalence of Livestock Diseases in the World

Key Market Restraints:

  • High Cost of Eubiotics

Key Opportunities:

  • High Demand for Feed Additives Owing to the Rising Cost Of Natural Feed Products

Companies Covered in the report:

  • BASF SE, Lallemand Inc., Cargill Incorporated, Calpis Co. Ltd, Chr. Hansen A/S., Kemin Industries Inc., and Other Major Players

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EUBIOTICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EUBIOTICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EUBIOTICS MARKET COMPETITIVE RIVALRY
TABLE 005. EUBIOTICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. EUBIOTICS MARKET THREAT OF SUBSTITUTES
TABLE 007. EUBIOTICS MARKET BY PRODUCT TYPE
TABLE 008. PROBIOTICS MARKET OVERVIEW (2016-2028)
TABLE 009. PREBIOTICS MARKET OVERVIEW (2016-2028)
TABLE 010. EXOGENOUS ENZYMES MARKET OVERVIEW (2016-2028)
TABLE 011. ORGANIC ACIDS MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. EUBIOTICS MARKET BY FORM
TABLE 014. DRY MARKET OVERVIEW (2016-2028)
TABLE 015. LIQUID MARKET OVERVIEW (2016-2028)
TABLE 016. EUBIOTICS MARKET BY FUNCTION
TABLE 017. NUTRITION & GUT HEALTH MARKET OVERVIEW (2016-2028)
TABLE 018. PRODUCTION MARKET OVERVIEW (2016-2028)
TABLE 019. YIELD MARKET OVERVIEW (2016-2028)
TABLE 020. IMMUNITY MARKET OVERVIEW (2016-2028)
TABLE 021. EUBIOTICS MARKET BY LIVESTOCK
TABLE 022. RUMINANT MARKET OVERVIEW (2016-2028)
TABLE 023. SWINE MARKET OVERVIEW (2016-2028)
TABLE 024. POULTRY MARKET OVERVIEW (2016-2028)
TABLE 025. AQUACULTURE MARKET OVERVIEW (2016-2028)
TABLE 026. NORTH AMERICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 027. NORTH AMERICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 028. NORTH AMERICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 029. NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 030. N EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROPE EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 032. EUROPE EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 033. EUROPE EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 034. EUROPE EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 035. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 036. ASIA PACIFIC EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 037. ASIA PACIFIC EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 038. ASIA PACIFIC EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 039. ASIA PACIFIC EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 040. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 045. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 046. SOUTH AMERICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 047. SOUTH AMERICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 048. SOUTH AMERICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 049. SOUTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 050. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 051. BASF SE: SNAPSHOT
TABLE 052. BASF SE: BUSINESS PERFORMANCE
TABLE 053. BASF SE: PRODUCT PORTFOLIO
TABLE 054. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. LALLEMAND INC.: SNAPSHOT
TABLE 055. LALLEMAND INC.: BUSINESS PERFORMANCE
TABLE 056. LALLEMAND INC.: PRODUCT PORTFOLIO
TABLE 057. LALLEMAND INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. CARGILL INCORPORATED: SNAPSHOT
TABLE 058. CARGILL INCORPORATED: BUSINESS PERFORMANCE
TABLE 059. CARGILL INCORPORATED: PRODUCT PORTFOLIO
TABLE 060. CARGILL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. CALPIS CO. LTD: SNAPSHOT
TABLE 061. CALPIS CO. LTD: BUSINESS PERFORMANCE
TABLE 062. CALPIS CO. LTD: PRODUCT PORTFOLIO
TABLE 063. CALPIS CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. CHR. HANSEN A/S.: SNAPSHOT
TABLE 064. CHR. HANSEN A/S.: BUSINESS PERFORMANCE
TABLE 065. CHR. HANSEN A/S.: PRODUCT PORTFOLIO
TABLE 066. CHR. HANSEN A/S.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. KEMIN INDUSTRIES INC.: SNAPSHOT
TABLE 067. KEMIN INDUSTRIES INC.: BUSINESS PERFORMANCE
TABLE 068. KEMIN INDUSTRIES INC.: PRODUCT PORTFOLIO
TABLE 069. KEMIN INDUSTRIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. LESAFFRE GROUP: SNAPSHOT
TABLE 070. LESAFFRE GROUP: BUSINESS PERFORMANCE
TABLE 071. LESAFFRE GROUP: PRODUCT PORTFOLIO
TABLE 072. LESAFFRE GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. ADVANCED BIONUTRITION CORPORATION: SNAPSHOT
TABLE 073. ADVANCED BIONUTRITION CORPORATION: BUSINESS PERFORMANCE
TABLE 074. ADVANCED BIONUTRITION CORPORATION: PRODUCT PORTFOLIO
TABLE 075. ADVANCED BIONUTRITION CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. BEHN MEYER: SNAPSHOT
TABLE 076. BEHN MEYER: BUSINESS PERFORMANCE
TABLE 077. BEHN MEYER: PRODUCT PORTFOLIO
TABLE 078. BEHN MEYER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. KONINKLIJKE DSM N.V.: SNAPSHOT
TABLE 079. KONINKLIJKE DSM N.V.: BUSINESS PERFORMANCE
TABLE 080. KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 081. KONINKLIJKE DSM N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. NOVOZYMES.: SNAPSHOT
TABLE 082. NOVOZYMES.: BUSINESS PERFORMANCE
TABLE 083. NOVOZYMES.: PRODUCT PORTFOLIO
TABLE 084. NOVOZYMES.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. FRIESLAND CAMPINA: SNAPSHOT
TABLE 085. FRIESLAND CAMPINA: BUSINESS PERFORMANCE
TABLE 086. FRIESLAND CAMPINA: PRODUCT PORTFOLIO
TABLE 087. FRIESLAND CAMPINA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. ALLTECH: SNAPSHOT
TABLE 088. ALLTECH: BUSINESS PERFORMANCE
TABLE 089. ALLTECH: PRODUCT PORTFOLIO
TABLE 090. ALLTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. NOVUS INTERNATIONAL: SNAPSHOT
TABLE 091. NOVUS INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 092. NOVUS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 093. NOVUS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. E.I.DU PONT DE NEMOURS AND COMPANY: SNAPSHOT
TABLE 094. E.I.DU PONT DE NEMOURS AND COMPANY: BUSINESS PERFORMANCE
TABLE 095. E.I.DU PONT DE NEMOURS AND COMPANY: PRODUCT PORTFOLIO
TABLE 096. E.I.DU PONT DE NEMOURS AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 096. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 097. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 098. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 099. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EUBIOTICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EUBIOTICS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. PROBIOTICS MARKET OVERVIEW (2016-2028)
FIGURE 013. PREBIOTICS MARKET OVERVIEW (2016-2028)
FIGURE 014. EXOGENOUS ENZYMES MARKET OVERVIEW (2016-2028)
FIGURE 015. ORGANIC ACIDS MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. EUBIOTICS MARKET OVERVIEW BY FORM
FIGURE 018. DRY MARKET OVERVIEW (2016-2028)
FIGURE 019. LIQUID MARKET OVERVIEW (2016-2028)
FIGURE 020. EUBIOTICS MARKET OVERVIEW BY FUNCTION
FIGURE 021. NUTRITION & GUT HEALTH MARKET OVERVIEW (2016-2028)
FIGURE 022. PRODUCTION MARKET OVERVIEW (2016-2028)
FIGURE 023. YIELD MARKET OVERVIEW (2016-2028)
FIGURE 024. IMMUNITY MARKET OVERVIEW (2016-2028)
FIGURE 025. EUBIOTICS MARKET OVERVIEW BY LIVESTOCK
FIGURE 026. RUMINANT MARKET OVERVIEW (2016-2028)
FIGURE 027. SWINE MARKET OVERVIEW (2016-2028)
FIGURE 028. POULTRY MARKET OVERVIEW (2016-2028)
FIGURE 029. AQUACULTURE MARKET OVERVIEW (2016-2028)
FIGURE 030. NORTH AMERICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. EUROPE EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. ASIA PACIFIC EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. MIDDLE EAST & AFRICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. SOUTH AMERICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Eubiotics Market research report?

The forecast period in the Eubiotics Market research report is 2022-2028.

Who are the key players in Eubiotics Market?

BASF SE, Lallemand Inc., Cargill Incorporated, Calpis Co. Ltd, Chr. Hansen A/S., Kemin Industries Inc., Lesaffre Group, Advanced BioNutrition Corporation, Behn Meyer, Koninklijke DSM N.V., Novozymes., Friesland Campina, Alltech, Novus International, E.I.du Pont de Nemours and Company and others , and Other Major Players.

What are the segments of Eubiotics Market?

Eubiotics Market is segmented into Product Type, Form, Function, Livestock and region. By Product Type, the market is categorized into Probiotics, Prebiotics, Exogenous Enzymes, Organic Acids, Others. By Form, the market is categorized into Dry, Liquid. By Function the market is categorized into Nutrition & Gut Health, Production, Yield, and Immunity. By Livestock, the market is categorized into Ruminant, Swine, Poultry, and Aquaculture. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Eubiotics Market?

Eubiotics refer to the products that are utilized for sustaining an effective balance of microflora in the gastrointestinal tract. Eubiotics are required for making well-nourished animals. Eubiotics secure that a healthy balance of micro-flora is maintained in the gastrointestinal tract of an animal.

How big is Eubiotics Market?

Global Eubiotics Market was valued at USD 5.57 Billion in 2021 and is expected to reach USD 9.25 Billion by the year 2028, at a CAGR of 7.52% .